Transmembrane protein 16A/anoctamin 1 inhibitor T16A(inh)-A01 reversed monocrotaline-induced rat pulmonary arterial hypertension

Transmembrane protein 16A was involved in the development of the monocrotaline-induced pulmonary arterial hypertension model through ERK1/2 activation, and it was considered as potential target for pulmonary arterial hypertension treatment. A pulmonary arterial hypertension rat model was established...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jianye, Liu, Wenyuan, Lv, Wenjing, Han, Xiaohua, Kong, Qingnuan, Wu, Yuhui, Liu, Xin, Han, Ying, Shi, Chunying, Jia, Xiujuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826276/
https://www.ncbi.nlm.nih.gov/pubmed/35154665
http://dx.doi.org/10.1177/2045894020946670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826276/
https://www.ncbi.nlm.nih.gov/pubmed/35154665
http://dx.doi.org/10.1177/2045894020946670

Ejemplares similares